131 related articles for article (PubMed ID: 20736801)
21. Tetracycline release from tripolyphosphate-chitosan cross-linked sponge: a preliminary in vitro study.
Shen EC; Wang C; Fu E; Chiang CY; Chen TT; Nieh S
J Periodontal Res; 2008 Dec; 43(6):642-8. PubMed ID: 18624950
[TBL] [Abstract][Full Text] [Related]
22. The rationale of antibiotic prophylaxis in total hip replacement arthroplasty.
Rangno RE
Clin Orthop Relat Res; 1973 Oct; (96):206-9. PubMed ID: 4749818
[No Abstract] [Full Text] [Related]
23. An Effective Negative Pressure Wound Therapy-Compatible Local Antibiotic Delivery Device.
Rand BCC; Wenke JC
J Orthop Trauma; 2017 Dec; 31(12):631-635. PubMed ID: 28742785
[TBL] [Abstract][Full Text] [Related]
24. Release of vancomycin and teicoplanin from a plasticized and resorbable gelatin sponge: in vitro investigation of a new antibiotic delivery system with glycopeptides.
Drognitz O; Thorn D; Krüger T; Gatermann SG; Iven H; Bruch HP; Muhl E
Infection; 2006 Feb; 34(1):29-34. PubMed ID: 16501900
[TBL] [Abstract][Full Text] [Related]
25. In vitro release and characterization of chitosan films as dexamethasone carrier.
Rodrigues LB; Leite HF; Yoshida MI; Saliba JB; Cunha AS; Faraco AA
Int J Pharm; 2009 Feb; 368(1-2):1-6. PubMed ID: 18955123
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic-releasing mesh coating to reduce prosthetic sepsis: an in vivo study.
Harth KC; Rosen MJ; Thatiparti TR; Jacobs MR; Halaweish I; Bajaksouzian S; Furlan J; von Recum HA
J Surg Res; 2010 Oct; 163(2):337-43. PubMed ID: 20538302
[TBL] [Abstract][Full Text] [Related]
27. Norfloxacin-loaded chitosan sponges as wound dressing material.
Denkbaş EB; Oztürk E; Ozdemir N; Keçeci K; Agalar C
J Biomater Appl; 2004 Apr; 18(4):291-303. PubMed ID: 15070516
[TBL] [Abstract][Full Text] [Related]
28. In vivo drug release and antibacterial properties of vancomycin loaded hydroxyapatite/chitosan composite.
Zhang J; Wang C; Wang J; Qu Y; Liu G
Drug Deliv; 2012; 19(5):264-9. PubMed ID: 22823893
[TBL] [Abstract][Full Text] [Related]
29. Sustained release of vancomycin from a new biodegradable glue to prevent methicillin-resistant Staphylococcus aureus graft infection.
Morishima M; Marui A; Yanagi S; Nomura T; Nakajima N; Hyon SH; Ikeda T; Sakata R
Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):52-5. PubMed ID: 20360210
[TBL] [Abstract][Full Text] [Related]
30. Chitosan sponges for local synergistic infection therapy: a pilot study.
Smith JK; Moshref AR; Jennings JA; Courtney HS; Haggard WO
Clin Orthop Relat Res; 2013 Oct; 471(10):3158-64. PubMed ID: 23604649
[TBL] [Abstract][Full Text] [Related]
31. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
Keeling WB; Myers AR; Stone PA; Heller L; Widen R; Back MR; Johnson BL; Bandyk DF; Shames ML
J Surg Res; 2009 Dec; 157(2):223-6. PubMed ID: 19560786
[TBL] [Abstract][Full Text] [Related]
32. Development of a biodegradable antibiotic delivery system.
Lin SS; Ueng SW; Liu SJ; Chan EC; Chao EK; Tsai CH; Chen KT; Wei FC; Shih CH
Clin Orthop Relat Res; 1999 May; (362):240-50. PubMed ID: 10335303
[TBL] [Abstract][Full Text] [Related]
33. Use of the biodegradable polymer chitosan as a vehicle for applying drugs to the inner ear.
Saber A; Strand SP; Ulfendahl M
Eur J Pharm Sci; 2010 Jan; 39(1-3):110-5. PubMed ID: 19931387
[TBL] [Abstract][Full Text] [Related]
34. Release behavior of amoxicillin from glycol chitosan superporous hydrogels.
Park J; Kim D
J Biomater Sci Polym Ed; 2009; 20(5-6):853-62. PubMed ID: 19323894
[TBL] [Abstract][Full Text] [Related]
35. Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control.
Parker AC; Jennings JA; Bumgardner JD; Courtney HS; Lindner E; Haggard WO
J Biomed Mater Res B Appl Biomater; 2013 Jan; 101(1):110-23. PubMed ID: 22997172
[TBL] [Abstract][Full Text] [Related]
36. Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units.
Humphreys H; Smyth EG
J Hosp Infect; 2005 Mar; 59(3):259-61; author reply 263-6. PubMed ID: 15694985
[No Abstract] [Full Text] [Related]
37. Chitosan-vancomysin composite biomaterial as a laser activated surgical adhesive with regional antimicrobial activity.
Foster LJ; Thomson K; Marçal H; Butt J; Watson SL; Wakefield D
Biomacromolecules; 2010 Dec; 11(12):3563-70. PubMed ID: 21080623
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic-eluting medical devices for various applications.
Zilberman M; Elsner JJ
J Control Release; 2008 Sep; 130(3):202-15. PubMed ID: 18687500
[TBL] [Abstract][Full Text] [Related]
39. Chitosan salts as nasal sustained delivery systems for peptidic drugs.
Cerchiara T; Luppi B; Bigucci F; Zecchi V
J Pharm Pharmacol; 2003 Dec; 55(12):1623-7. PubMed ID: 14738587
[TBL] [Abstract][Full Text] [Related]
40. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
